



Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
Nicotinic Acetylcholine Receptor delta/CHRND Double Nickase Plasmid (h) | sc-404001-NIC | 20 µg | $410.00 | |||
Nicotinic Acetylcholine Receptor delta/CHRND Double Nickase Plasmid (h2) | sc-404001-NIC-2 | 20 µg | $410.00 |
CHRND encodes the delta subunit of the muscle-type nicotinic acetylcholine receptor (nAChR), a pentameric ligand-gated cation channel concentrated at the postsynaptic membrane of the neuromuscular junction. Upon acetylcholine binding, the receptor opens to permit Na⁺ and K⁺ flux, driving endplate depolarization and coupling synaptic transmission to skeletal muscle contraction. CHRND function is integrated with pathways governing synapse assembly and maturation, including agrin–LRP4–MuSK signaling, receptor clustering, and stabilization by rapsyn and associated scaffolds. Genetic perturbation of muscle nAChR subunits, including CHRND, is linked to disorders of neuromuscular transmission such as congenital myasthenic syndromes, making this gene relevant for mechanistic studies of synaptic excitability and receptor biogenesis.
Nicotinic Acetylcholine Receptor delta/CHRND Double Nickase Plasmid (h) consists of a matched pair of plasmids engineered for high-specificity editing of the CHRND locus in human cell lines. Each plasmid expresses a Cas9 D10A nickase and a distinct sgRNA targeting opposite DNA strands within CHRND. When directed to adjacent sites on opposite DNA strands, the two nickases generate offset single-strand nicks that together produce a staggered double-strand break, requiring coordinated on-target activity from both guides. The resulting DNA break is resolved by endogenous cellular repair pathways, most commonly through non-homologous end joining (NHEJ), leading to insertions or deletions that disrupt CHRND function. By requiring dual sgRNA engagement at the target locus, the double nicking approach enhances editing specificity and provides a complementary CRISPR strategy for applications where additional control over targeting precision is desired.
To support efficient identification of edited cells, one plasmid encodes GFP for fluorescent visualization of transfected populations, while the companion plasmid carries a puromycin resistance gene for antibiotic selection. Together, these features support efficient enrichment of co-transfected populations and simplify the validation of CHRND-disrupted clones.
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.